3.54
price up icon0.57%   0.02
after-market アフターアワーズ: 3.56 0.02 +0.56%
loading
前日終値:
$3.52
開ける:
$3.59
24時間の取引高:
4.93M
Relative Volume:
1.95
時価総額:
$582.73M
収益:
$361.51M
当期純損益:
$102.18M
株価収益率:
5.9257
EPS:
0.5974
ネットキャッシュフロー:
$112.21M
1週間 パフォーマンス:
-2.48%
1か月 パフォーマンス:
+1.14%
6か月 パフォーマンス:
+8.59%
1年 パフォーマンス:
+406.58%
1日の値動き範囲:
Value
$3.49
$3.65
1週間の範囲:
Value
$3.49
$3.79
52週間の値動き範囲:
Value
$0.6601
$5.78

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
名前
Ironwood Pharmaceuticals Inc
Name
セクター
Healthcare (1104)
Name
電話
617-621-7722
Name
住所
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
職員
100
Name
Twitter
@ironwoodpharma
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
IRWD's Discussions on Twitter

Compare IRWD vs TAK, HLN, TEVA, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IRWD icon
IRWD
Ironwood Pharmaceuticals Inc
3.54 582.73M 361.51M 102.18M 112.21M 0.5974
TAK icon
TAK
Takeda Pharmaceutical Co Adr
15.63 49.39B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
8.96 39.55B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
31.48 36.66B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
78.71 33.00B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
536.59 22.78B 3.17B 1.29B 1.01B 27.09

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-05 アップグレード Citizens JMP Mkt Perform → Mkt Outperform
2025-04-15 ダウングレード Jefferies Buy → Hold
2025-04-15 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 開始されました Leerink Partners Market Perform
2024-08-08 ダウングレード CapitalOne Overweight → Equal Weight
2024-01-17 開始されました Craig Hallum Buy
2023-12-14 開始されました Wells Fargo Overweight
2023-11-09 開始されました Jefferies Buy
2023-09-28 開始されました JMP Securities Mkt Outperform
2022-09-02 開始されました CapitalOne Overweight
2022-04-22 開始されました Piper Sandler Overweight
2020-09-30 ダウングレード Wells Fargo Overweight → Equal Weight
2020-06-17 開始されました Northland Capital Outperform
2019-07-10 再開されました Credit Suisse Neutral
2019-03-27 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-02-25 アップグレード H.C. Wainwright Sell → Neutral
2019-01-24 アップグレード JP Morgan Underweight → Neutral
2018-11-07 ダウングレード Credit Suisse Outperform → Neutral
2018-11-07 ダウングレード JP Morgan Neutral → Underweight
2018-07-23 開始されました H.C. Wainwright Sell
2018-05-09 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-01-05 ダウングレード BofA/Merrill Buy → Underperform
2017-12-06 ダウングレード Mizuho Buy → Neutral
2017-07-21 ダウングレード JP Morgan Overweight → Neutral
2017-05-03 開始されました Wells Fargo Outperform
2017-04-07 繰り返されました Mizuho Buy
2017-02-22 繰り返されました Barclays Equal Weight
2016-11-04 繰り返されました Mizuho Buy
2016-10-24 繰り返されました Wedbush Neutral
2016-10-10 繰り返されました Mizuho Buy
2016-09-27 繰り返されました WallachBeth Hold
すべてを表示

Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース

pulisher
Jun 19, 2026

Ironwood Pharmaceuticals StockAnalyst snapshot and sector review at week’s end - AD HOC NEWS

Jun 19, 2026
pulisher
Jun 18, 2026

Ironwood Pharmaceuticals (IRWD) adds 10M shares to 2019 equity incentive plan - Stock Titan

Jun 18, 2026
pulisher
Jun 18, 2026

Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Ironwood Pharmaceuticals Inc - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Ironwood Pharmaceuticals Inc (IRWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Director Julie Mchugh Sells 21,571 Shares of Ironwood Pharmaceuticals Inc (IRWD) - GuruFocus

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood Pharmaceuticals Inc (IRWD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood Pharmaceuticals Inc (IRWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood (IRWD) director Jay Shepard receives 63,481-share restricted stock grant - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood (NASDAQ: IRWD) director awarded restricted stock that vests before next meeting - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood (IRWD) director Marla Kessler receives 63,481-share restricted stock grant - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood Pharmaceuticals (IRWD) director receives 63,481-share grant - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood Pharmaceuticals (IRWD) director granted 63,481 restricted shares in latest Form 4 - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Ironwood (NASDAQ: IRWD) director sells shares and receives new stock grant - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Director Catherine Moukheibir receives 63,481 Ironwood (IRWD) restricted shares - Stock Titan

Jun 17, 2026
pulisher
Jun 16, 2026

[144] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan

Jun 16, 2026
pulisher
Jun 16, 2026

IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill

Jun 16, 2026
pulisher
Jun 15, 2026

Ironwood Pharmaceuticals (IRWD) Jefferies London Healthcare Conference 2024 Summary - Quartr

Jun 15, 2026
pulisher
Jun 15, 2026

Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026 - TradingView

Jun 15, 2026
pulisher
Jun 15, 2026

Ironwood Pharmaceuticals (IRWD) retires $200M 2026 convertible notes in cash - Stock Titan

Jun 15, 2026
pulisher
Jun 14, 2026

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - MSN

Jun 14, 2026
pulisher
Jun 12, 2026

Ironwood Pharmaceuticals (IRWD) Tops Healthcare Sector with Stro - GuruFocus

Jun 12, 2026
pulisher
Jun 12, 2026

These healthcare stocks are combining strong gains with reasonable prices (XLV:NYSEARCA) - Seeking Alpha

Jun 12, 2026
pulisher
Jun 11, 2026

Can Linzess Continue Driving IRWD's Revenue Growth Through 2026? - Yahoo Finance

Jun 11, 2026
pulisher
Jun 07, 2026

· SEC Filing - MLQ.ai

Jun 07, 2026
pulisher
Jun 05, 2026

IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Chart - ChartMill

Jun 05, 2026
pulisher
Jun 04, 2026

IRWD: Apraglutide and LINZESS drive growth, with new trials, debt reduction, and market leadership ahead - TradingView

Jun 04, 2026
pulisher
Jun 02, 2026

Ironwood Pharmaceuticals Signals Blockbuster Momentum in 2026 - The Globe and Mail

Jun 02, 2026
pulisher
Jun 02, 2026

Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price, News, Quote & History - Yahoo Finance

Jun 02, 2026
pulisher
Jun 02, 2026

Ironwood Pharmaceuticals Expands Linzess Use and Drives Record Q1 2026 Revenue - asatunews.co.id

Jun 02, 2026
pulisher
Jun 02, 2026

Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess? - Insider Monkey

Jun 02, 2026
pulisher
Jun 01, 2026

Ironwood (IRWD) Q1 2026 Earnings Call Transcript - The Globe and Mail

Jun 01, 2026
pulisher
Jun 01, 2026

Earnings Preview: IRWD to Report Financial Results Pre-market on May 07 - Moomoo

Jun 01, 2026
pulisher
May 31, 2026

Ironwood Pharmaceuticals (IRWD) Proxy filing Summary - Quartr

May 31, 2026
pulisher
May 30, 2026

Ironwood reiterates 2026 LINZESS guidance of $1.125B-$1.175B as STARS-2 initiation nears - MSN

May 30, 2026
pulisher
May 29, 2026

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2026 - BioSpace

May 29, 2026
pulisher
May 28, 2026

Ironwood Pharmaceuticals to Present at Jefferies Global Healthcare Conference - geneonline.com

May 28, 2026
pulisher
May 28, 2026

Ironwood Pharmaceuticals, Inc. (IRWD) stock price, news, quote and history - Yahoo Finance UK

May 28, 2026
pulisher
May 28, 2026

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference - investor.ironwoodpharma.com

May 28, 2026
pulisher
May 27, 2026

Ironwood Pharmaceuticals (IRWD) Gains FDA Approval for Linzess i - GuruFocus

May 27, 2026
pulisher
May 27, 2026

FDA approves Linzess for children ages 2-5 with constipation - Investing.com UK

May 27, 2026
pulisher
May 27, 2026

Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation - Seeking Alpha

May 27, 2026
pulisher
May 27, 2026

FDA approves constipation drug LINZESS for kids as young as 2 - Stock Titan

May 27, 2026
pulisher
May 26, 2026

Ironwood Pharmaceuticals (IRWD) Receives Strong Buy Rating Follo - GuruFocus

May 26, 2026
pulisher
May 26, 2026

Ironwood Pharmaceuticals (IRWD) Earns Strong Buy Rating from Qua - GuruFocus

May 26, 2026
pulisher
May 21, 2026

Ironwood Pharmaceuticals: A Contrarian Buy Opportunity (NASDAQ:IRWD) - Seeking Alpha

May 21, 2026
pulisher
May 21, 2026

Ironwood Pharmaceuticals (IRWD) sets interim CFO fee and RSU grant - Stock Titan

May 21, 2026

Ironwood Pharmaceuticals Inc (IRWD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$35.47
price up icon 11.23%
RDY RDY
$13.29
price up icon 1.06%
$24.22
price up icon 3.55%
$158.29
price down icon 0.45%
$15.37
price down icon 2.29%
$536.59
price down icon 2.70%
大文字化:     |  ボリューム (24 時間):